Caitlin Cronin
Stock Analyst at Canaccord Genuity
(0.52)
# 2536
Out of 5,370 analysts
29
Total ratings
43.75%
Success rate
-2.42%
Average return
Main Sectors:
Top Industries:
Name | Action | PT | Current | % Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
ENOV Enovis | Maintains: Buy | 75 70 | 32.27 | 116.92% | 2 | May 14, 2025 | |
AXGN Axogen | Maintains: Buy | 26 24 | 9.74 | 146.41% | 6 | May 13, 2025 | |
SNN Smith & Nephew | Maintains: Hold | 27 28 | 29.27 | -4.34% | 2 | May 1, 2025 | |
INMD InMode | Maintains: Hold | 17 15 | 13.42 | 11.77% | 3 | Apr 29, 2025 | |
TELA TELA Bio | Maintains: Buy | 12 7 | 1.62 | 332.1% | 4 | Mar 21, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 15 15 | 6.57 | 128.31% | 1 | Mar 17, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 64 67 | 41.62 | 60.98% | 3 | Feb 3, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 3 4 | 3.25 | 23.08% | 2 | Nov 14, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 20 20 | 10.98 | 82.15% | 3 | Aug 30, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Hold | 130 | 92.12 | 41.12% | 1 | Feb 23, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 79 | 58.89 | 34.15% | 1 | Feb 21, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 270 12 | 8.18 | 46.7% | 1 | Nov 14, 2023 |